Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
7.50
+0.05 (0.67%)
Aug 12, 2025, 10:43 AM EDT
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
$605,506
Profits / Employee
-$44,822
Market Cap
29.29B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Dec 31, 2021 | 95,950 | -5 | -0.01% |
| Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Silence Therapeutics | 116 |
Bayer Aktiengesellschaft News
- 3 hours ago - Bayer and Kumquat Biosciences Enter Global Exclusive License and Collaboration in Precision Oncology - Business Wire
- 7 hours ago - Bayer inks $1.3 billion deal with Kumquat Biosciences for cancer drug development - Seeking Alpha
- 7 hours ago - Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal - Reuters
- 8 hours ago - Bayer, Kumquat Biosciences Team Up on New Potential Cancer Drug - WSJ
- 5 days ago - Bayer A.G. (BAYZF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Bayer A.G. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 5 days ago - Bayer drops as core businesses underperform in Q2 - Seeking Alpha
- 6 days ago - Bayer AG Non-GAAP EPS of Є1.23, revenue of Є10.74B; raises FY outlook - Seeking Alpha